Autoimmune Hepatitis Beyond Steroids: Effective Trial Design and Attention to Quality of Life
Standard
Autoimmune Hepatitis Beyond Steroids: Effective Trial Design and Attention to Quality of Life. / Schramm, Christoph.
in: Clin Liver Dis (Hoboken), Jahrgang 14, Nr. 1, 07.2019, S. 33-36.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Review › Forschung
Harvard
Schramm, C 2019, 'Autoimmune Hepatitis Beyond Steroids: Effective Trial Design and Attention to Quality of Life', Clin Liver Dis (Hoboken), Jg. 14, Nr. 1, S. 33-36. https://doi.org/10.1002/cld.816
APA
Schramm, C. (2019). Autoimmune Hepatitis Beyond Steroids: Effective Trial Design and Attention to Quality of Life. Clin Liver Dis (Hoboken), 14(1), 33-36. https://doi.org/10.1002/cld.816
Vancouver
Schramm C. Autoimmune Hepatitis Beyond Steroids: Effective Trial Design and Attention to Quality of Life. Clin Liver Dis (Hoboken). 2019 Jul;14(1):33-36. https://doi.org/10.1002/cld.816
Bibtex
@article{e47d1ea1f3ee4eafa58cad3717100605,
title = "Autoimmune Hepatitis Beyond Steroids: Effective Trial Design and Attention to Quality of Life",
author = "Christoph Schramm",
year = "2019",
month = jul,
doi = "10.1002/cld.816",
language = "English",
volume = "14",
pages = "33--36",
journal = "Clin Liver Dis (Hoboken)",
issn = "2046-2484",
publisher = "Wiley",
number = "1",
}
RIS
TY - JOUR
T1 - Autoimmune Hepatitis Beyond Steroids: Effective Trial Design and Attention to Quality of Life
AU - Schramm, Christoph
PY - 2019/7
Y1 - 2019/7
U2 - 10.1002/cld.816
DO - 10.1002/cld.816
M3 - SCORING: Review article
C2 - 31391935
VL - 14
SP - 33
EP - 36
JO - Clin Liver Dis (Hoboken)
JF - Clin Liver Dis (Hoboken)
SN - 2046-2484
IS - 1
ER -
